Tuesday 13 October 2026
Export ALT’s income statement to Excel — free account
Altimmune, Inc.
Altimmune, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41,000.00, up 105.0% from fiscal 2024. In the quarter to June 2026, revenue grew 520.0%, EPS grew 55.6%, free cash flow fell 25.3% and total debt rose 142.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.48
0.08
−3.13%
Follow ALT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 2 | — | — | 2 | 4 | 3 | 3 | 4 | 2 |
Altman Z-Score |
0.23 | 12.45 | 18.25 | 18.47 | 9.20 | 8.32 | (2.17) | (4.08) | (3.25) | — |
P/S ratio |
6,914.26 | 25,596.73 | 1,314.92 | 0.00 | 85.75 | 35.33 | 4.28 | 0.56 | 2.41 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
0.63 | (3.94) | 8.19 | 5.76 | 8.83 | 14.19 | (0.93) | (0.16) | (5.77) | 0.70 |
Beneish M-Score |
(3.17) | 6.02 | — | — | (3.77) | 1.38 | (3.96) | (5.99) | (0.80) | (0.21) |
P/Operating CF |
(16.35) | (28.03) | (33.88) | (42.38) | (17.21) | (21.77) | (12.39) | (1.12) | (5.39) | 0.00 |
P/B ratio |
1.41 | 4.15 | 2.89 | 3.96 | 1.90 | 1.28 | 0.55 | 0.12 | 0.66 | 0.00 |
Price to Tangible BV |
1.50 | 4.61 | 3.08 | 4.24 | 2.03 | 1.36 | 0.76 | 0.17 | 38.48 | 0.00 |
EV/Sales |
1,717.80 | 19,023.93 | 851.59 | (8,079.20) | 42.88 | 9.15 | (1.86) | (2.69) | 1.32 | (0.81) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.54 | 1.58 | 0.00 | 0.24 |
EV/Operating CF |
(1.17) | (4.76) | (4.79) | (8.78) | (2.42) | (2.18) | 1.13 | 2.96 | (0.70) | 0.41 |
EV/FCF |
(1.17) | (4.75) | (4.77) | (8.73) | (2.09) | (2.16) | 1.12 | 2.68 | (0.70) | 0.40 |
Quick Ratio |
18.35 | 12.90 | 16.69 | 10.99 | 10.73 | 19.00 | 9.92 | 8.58 | 5.85 | 0.74 |
Current Ratio |
18.55 | 13.11 | 17.26 | 11.31 | 11.17 | 19.16 | 10.04 | 8.70 | 6.11 | 0.82 |
Net Debt/EBITDA |
2.49 | 1.24 | 2.31 | 2.10 | 1.96 | 3.95 | 1.78 | 1.92 | 0.77 | 0.26 |
Debt/Assets |
12.25% | 0.00% | 0.00% | 0.32% | 0.51% | 0.60% | 2.75% | 0.92% | 0.00% | 0.04% |
Debt/Equity |
0.15 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.01 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.05 | 0.11 | 0.18 | 0.21 | 0.11 |
Operating CF/Net income |
0.77 | 0.84 | 0.86 | 0.74 | 0.81 | 0.70 | 0.46 | 0.22 | 0.39 | 0.55 |
Capex/Depreciation |
0.01 | 0.00 | 0.00 | 0.61 | (22.34) | (0.80) | (0.07) | (0.04) | 0.00 | (1.63) |
Interest Coverage |
(57.76) | (11,463.56) | (2,740.83) | (10,967.50) | (19,382.80) | (5,829.65) | (9,302.23) | (144.17) | (321.07) | (288.10) |
| (50.57%) | (59.86%) | (46.63%) | (44.07%) | (45.69%) | (36.14%) | (44.70%) | (96.86%) | (143.46%) | (46.90%) | |
| (42.03%) | (54.33%) | (42.36%) | (39.79%) | (41.85%) | (32.79%) | (38.55%) | (72.13%) | (101.26%) | (39.32%) | |
ROIC |
0.00% | 0.00% | 0.00% | (5,217.65%) | (610.37%) | (300.78%) | (131.45%) | (185.13%) | (120.07%) | (23.62%) |
Return on Tangible Assets |
(33.43%) | (74.73%) | (44.64%) | (47.90%) | (51.84%) | (22.36%) | (57.34%) | (117.39%) | (253.87%) | 1,421.79% |
Average Days of Receivables |
15,463.54 | 56,885.25 | 4,158.09 | (13,639.19) | 483.27 | 551.76 | 103.83 | 157.96 | 345.61 | 134.28 |
Research and Development Expense of Revenue |
162,029.27% | 411,130.00% | 15,445.77% | (103,732.35%) | 1,690.27% | 608.12% | 306.23% | 178.68% | 171.41% | 223.15% |
Selling, General and Administrative Expense of Revenue |
68,531.71% | 104,830.00% | 4,257.51% | (25,197.06%) | 349.50% | 161.39% | 146.53% | 94.53% | 78.76% | 219.59% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.06 | 0.06 | 0.05 | 0.24 | 0.25 | 0.61 | 0.88 |
Share Based Compensation of Revenue |
39,209.76% | 71,965.00% | 2,497.65% | (11,913.24%) | 125.15% | 31.47% | 21.79% | 7.48% | 13.44% | 29.83% |
Graham Net Nets |
0.70 | 0.24 | 0.34 | 0.23 | 0.49 | 0.73 | 1.24 | 5.70 | (0.01) | (247.02) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(27.98%) | (18.59%) | (15.68%) | (11.32%) | (25.76%) | (16.93%) | (80.42%) | (844.58%) | (178.27%) | 2,962,960.00% |
Free Cash Flow Yield |
(21.30%) | (15.64%) | (13.58%) | (8.58%) | (23.95%) | (11.98%) | (38.82%) | (179.98%) | (78.62%) | (93,802.49%) |
Revenue per Share |
0.00 | 0.00 | 0.01 | 0.00 | 0.11 | 0.32 | 0.44 | 3.69 | 24.86 | 14.06 |
Operating CF per Share |
(0.77) | (1.12) | (1.42) | (1.33) | (1.90) | (1.34) | (0.73) | (3.35) | (46.80) | (27.60) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.30) | (0.01) | 0.00 | (0.36) | (0.37) | (0.96) |
Free Cash Flow per Share |
(0.77) | (1.12) | (1.42) | (1.34) | (2.19) | (1.35) | (0.73) | (3.71) | (47.17) | (28.56) |
Cash per Share |
3.10 | 1.86 | 3.72 | 3.94 | 4.61 | 8.42 | 2.84 | 12.26 | 28.49 | 12.49 |
Shareholders Equity per Share |
2.55 | 1.74 | 3.65 | 3.95 | 4.82 | 8.81 | 3.47 | 17.24 | 91.22 | 139.91 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.55 | 1.74 | 3.65 | 3.95 | 4.82 | 8.81 | 3.47 | 17.24 | 91.22 | 139.91 |
Free Cash Flow |
(67.55) | (79.85) | (75.86) | (62.71) | (90.55) | (34.65) | (9.63) | (10.39) | (20.37) | (6.57) |
Working Capital |
263.20 | 126.79 | 197.48 | 175.76 | 185.85 | 218.24 | 35.47 | 34.84 | 19.63 | (0.98) |
Capital Expenditures |
(0.01) | — | (0.05) | (0.13) | (12.31) | (0.34) | (0.03) | (1.00) | (0.16) | (0.22) |
Net Current Asset Value |
223.16 | 121.46 | 193.09 | 171.18 | 184.40 | 211.02 | 30.86 | 32.93 | (0.17) | (1.71) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 | 0.65 | 0.00 | 0.24 |
Capex to Sales |
0.27 | 0.00 | 0.11 | (1.85) | 2.79 | 0.04 | 0.01 | 0.10 | 0.01 | 0.07 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
(5.61) | (8.75) | 16.01 | (0.19) | 0.38 | 0.41 | 0.35 | 18.80 | 59.79 | 0.76 |
Cash ROIC |
(12.68%) | (31.26%) | (19.35%) | (16.91%) | (23.18%) | (7.82%) | (11.43%) | (12.49%) | (39.41%) | (18.73%) |
Accounts Receivable Turnover |
0.02 | 0.01 | 0.12 | (0.02) | 0.48 | 1.17 | 1.90 | 1.41 | 1.89 | 2.43 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
2.43 | 3.99 | 3.70 | 4.19 | 9.11 | 7.01 | 3.06 | 7.32 | 5.68 | 1.33 |
Average Payables |
1.46 | 1.14 | 3.44 | 3.42 | 1.32 | 0.32 | 0.20 | 0.25 | 1.07 | 1.26 |
Average Assets |
209.62 | 174.97 | 208.78 | 212.90 | 231.99 | 149.59 | 54.40 | 58.89 | 50.72 | 29.13 |
Average Common Equity |
174.20 | 158.80 | 189.70 | 192.21 | 212.51 | 135.70 | 46.92 | 43.85 | 35.80 | 24.43 |
Columns are period end dates